Global Pharmaceuticals & Biotech Most Popular Stocks

Hugel

Market Cap: ₩3.2t

Develops and manufactures biopharmaceuticals in South Korea and internationally.

Apogee Therapeutics

Market Cap: US$2.3b

A clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other inflammatory and immunology indications.

Shenzhen Hepalink Pharmaceutical Group

Market Cap: CN¥15.9b

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥15.9b

Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

Celcuity

Market Cap: US$2.2b

A clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.

Lotus Pharmaceutical

Market Cap: NT$67.1b

Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.

Ocular Therapeutix

Market Cap: US$2.2b

A biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditions using its bioresorbable hydrogel-based formulation technology in the United States.

89bio

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥15.5b

Engages in research, development, production, and sales of blood products in China.

Travere Therapeutics

Market Cap: US$2.2b

A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.

Disc Medicine

Market Cap: US$2.2b

A clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States.

Cidara Therapeutics

Market Cap: US$2.1b

Operates as a biotechnology company that focuses on developing targeted therapies for patients facing cancers and other serious diseases.

Galapagos

Market Cap: €1.8b

A biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe.

Agios Pharmaceuticals

Market Cap: US$2.1b

A biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States.

Beijing Hotgen Biotech

Market Cap: CN¥15.0b

Engages in the research, development, manufacture, and sale of medical and public safety inspection products of in-vitro diagnostic products in the field of biomedicine.

Tibet Cheezheng Tibetan Medicine

Market Cap: CN¥14.8b

Tibet Cheezheng Tibetan Medicine Co., Ltd.

Caregen

Market Cap: ₩2.9t

A biotechnology company, researches, develops, and commercializes biomimetic peptides worldwide.

Zhejiang Wolwo Bio-Pharmaceutical

Market Cap: CN¥14.7b

A biopharmaceutical company, engages in the research, development, production, and sale of pharmaceutical products for the diagnosis and treatment of allergic diseases in China and internationally.

Genus

Market Cap: UK£1.5b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

Sai Life Sciences

Market Cap: ₹179.8b

Operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally.

CanSino Biologics

Market Cap: HK$15.8b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Recursion Pharmaceuticals

Market Cap: US$2.0b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

Neuland Laboratories

Market Cap: ₹179.0b

Engages in the manufacture and sale of active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally.

Alembic Pharmaceuticals

Market Cap: ₹178.9b

An integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally.

Dermapharm Holding

Market Cap: €1.7b

Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.

Guangdong Zhongsheng Pharmaceutical

Market Cap: CN¥14.4b

Guangdong Zhongsheng Pharmaceutical Co., Ltd.

Arcutis Biotherapeutics

Market Cap: US$2.0b

A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.

Shanghai Shyndec Pharmaceutical

Market Cap: CN¥14.3b

Shanghai Shyndec Pharmaceutical Co., Ltd.

Mesoblast

Market Cap: AU$3.1b

Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.

Guangdong Taienkang Pharmaceutical

Market Cap: CN¥14.3b

Guangdong Taienkang Pharmaceutical Co., Ltd.

Bonesupport Holding

Market Cap: SEK 18.9b

An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.

Adaptive Biotechnologies

Market Cap: US$2.0b

A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.

Hisamitsu Pharmaceutical

Market Cap: JP¥296.3b

Manufactures and sells pharmaceuticals in Japan.

PegBio

Market Cap: HK$15.4b

A biopharmaceutical company, focuses on the research and development of medicines for chronic diseases in China.

Denali Therapeutics

Market Cap: US$2.0b

A biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases.

Mirxes Holding

Market Cap: HK$15.2b

A micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China.